VI.a. The danger of public resistance

VI.a. The danger of public resistance

Postby e-conference on Mon Apr 28, 2008 2:00 pm

Is there a danger that SB will meet the same resistance in the public as, for example, agricultural biotechnology?
e-conference
Site Admin
 
Posts: 34
Joined: Fri Feb 01, 2008 6:45 pm

Re: VI.a. The danger of public resistance

Postby helge on Tue May 27, 2008 5:50 pm

Many people in Europe seem to believe that new technologies automatically trigger public resistance as if the public was one of Pawlow's dogs and technology a bell ringing. Despite many examples to the contrary, this myth still prevails debates about new technologies, and in particular, biotechnologies. It is hard to imagine what need to happen in order to give this myth a final blow. Politicians and, in particular, scientists seem to be terribly anxious what people would come to think...
In reality, numerous investigations have shown that people are not against technology as such; rather, they are sceptical when it comes to a perceived skewed distribution of risks and benefits. Why is it likely that this will happen with Synthetic biology? Are there any hints at that'? I cannot see them. Perhaps SB one day will become as normal as mobile phones. Why should'nt it?
helge
 
Posts: 3
Joined: Wed May 07, 2008 5:29 pm
Institution: institute of technology assessment
austrian academy of sciences
Professional background / field of work: technology assessment

Re: VI.a. The danger of public resistance

Postby markus.fischer on Sat May 31, 2008 4:34 pm

I think at least in Europe there is a certain public bias for skepticism towards new technologies. One reason may be that some of the most important technological breakthroughs of the last 50 years have brought with them great risks or adverse effects (such as nuclear power), and these aspects have more often than not been aggressively downplayed by the proponents of these technologies.

It is important to show clearly the actual "distribution of risks and benefits" - and especially to show landmark projects with clear benefits to the broader public.

Mobile phones are an interesting analogy, because their development was at one point very rapid, with extremely benefitial effects for the end user. Those benefits became apparent and affordable much earlier than the broad public debate on the health risks of mobile telephony.
markus.fischer
 
Posts: 18
Joined: Tue Apr 29, 2008 3:10 pm
Institution: Entelechon GmbH
Professional background / field of work: Bioinformatics, software development for gene optimization and biosecurity.

Re: VI.a. The danger of public resistance

Postby scott.mohr on Mon Jun 09, 2008 7:03 pm

This is a **very key issue,* and like all such issues has many facets. People in general have a fear of the unknown (often with good reason) and also fear exploitation of things they care about by powerful, uncontrollable interests (also often with good reason). Synthetic biology still has a fairly low profile, so it's unlikely in the very near future to trigger a reaction such as that surrounding the early days of genetic engineering with the Asilomar conference and actions by city governments in Berkeley, CA and Cambridge, MA to impose moratoriums on research involving "recombinant DNA." Nevertheless, strident protests akin to those from that time 30 years ago or to the more recent objections in Europe to GM crops might well emerge, especially if something untoward happens in the course of a project that is labeled "Synthetic Biology." Such protests could seriously damage SB as a field, either by forcing premature, heavy-handed regulations on the laboratories that do SB research, or curtailment of public funding for such research.

In this area, the key operative word that describes the public susceptibility to a damagingly negative reaction is "unknown." As Markus has noted, publicity for successful, positive SB projects that clearly benefit humanity (e.g., Jay Keasling's work on biosynthesis of artemisinic acid in fermentation cultures) will help mitigate this problem of public ignorance. So too, I believe, do the iGEM competitions. It's an amazing experience to attend (as I have for the past two years) the annual iGEM jamboree. Even watching it on the web gives an idea of how enthusiastic the iGEM participants are after only a summer of work in an area that most of them knew little or nothing about beforehand (see http://2008.igem.org/Previous_iGEM_Competitions).

Beyond the "poster-child" projects and iGEM lies the much more difficult task of improving the public's scientific literacy in the areas of molecular and cellular biology. In the US a large proportion of the so-called "educated" public remains woefully ignorant of even the most rudimentary facts about gene expression, cellular metabolism, etc. If a technology like SB is to find a welcome reception in society it needs to have a prepared public...

Finally, I think it's important to temper the hyperbole with which SB is often described. No technology ever gets off the ground as swiftly as its backers usually promise, nor does it necessarily hit its stride as a major contributor to the health and welfare of society as quickly -- or even in the projected manner -- as the backers initially assume. Thus what might have aroused a very positive initial public perception can turn sour if it fails to deliver on its promises, and the inevitable critics can capitalize on every small mis-step to denigrate the field. Better to understate the potential benefits and then roll out a pleasant surprise.
scott.mohr
 
Posts: 5
Joined: Mon Jun 02, 2008 8:47 pm
Institution: Boston University
Boston, Massachusetts, USA &
MIT
Cambridge, Massachusetts, USA
Professional background / field of work: biophysical chemistry, bioinformatics & synthetic biology


Return to VI. Public perception, communication and the media

cron